Transarterial chemoembolization: Evidences from the literature and applications in hepatocellular carcinoma patients

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 7, Issue 16

Peer-Review Report of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Journal Information of This Article

Publication Name

World Journal of Hepatology

ISSN

1948-5182

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Review

World J Hepatol. Aug 8, 2015; 7(16): 2009-2019
Published online Aug 8, 2015. doi: 10.4254/wjh.v7.i16.2009

Table 1 Absolute and relative contraindications to transarterial chemoembolization

Absolute contraindications

Decompensated cirrhosis (Child-Pugh ≥ B8)

Extensive tumor with massive replacement of both entire lobes

Severely reduced portal vein flow

Technical impediments to hepatic intra-arterial treatment

Relative contraindications

Kidney failure

Severe cardiopulmonary comorbidities

Tumor size ≥ 10 cm

Untreated varices at high risk of bleeding

Bile-duct occlusion

Citation: Facciorusso A, Licinio R, Muscatiello N, Di Leo A, Barone M. Transarterial chemoembolization: Evidences from the literature and applications in hepatocellular carcinoma patients. World J Hepatol 2015; 7(16): 2009-2019
URL: https://www.wjgnet.com/1948-5182/full/v7/i16/2009.htm
DOI: https://dx.doi.org/10.4254/wjh.v7.i16.2009

Facciorusso A, Licinio R, Muscatiello N, Di Leo A, Barone M. Transarterial chemoembolization: Evidences from the literature and applications in hepatocellular carcinoma patients. World J Hepatol 2015; 7(16): 2009-2019 [PMID: 26261690 DOI: 10.4254/wjh.v7.i16.2009]

All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.